We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Adalimumab
Australian Public Assessment Report
Device/Product Name
Humira
Active ingredients
Adalimumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2013-01154-1-1
Submission Type
Extension of indications, New strength
Decision
Approved